• HOME
  •  > 
  • 薬学
  •  > 
  • 雑誌
  •  >  医学と薬学　76/11　2019年11月号

医学と薬学　76/11　2019年11月号

出版社： 自然科学社
発行日： 2019-10-27
分野： 薬学  >  雑誌
ISSN： 03893898
雑誌名：
特集： 生活習慣病予防に向けた栄養素機能
電子書籍版： 2019-10-27 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,540 円(税込)

購入する

目次

  • 特集　生活習慣病予防に向けた栄養素機能

    序文
    ビタミンDとフレイル・サルコペニア
    脂肪酸と動脈硬化症
    分岐鎖アミノ酸（BCAA）とインスリン抵抗性
    米タンパク質と慢性腎臓病
    ポリフェノールと肥満
    食塩と高血圧
    微量元素（亜鉛）と生活習慣病

    臨床報告
    　産褥期の貧血患者に対する人参養栄湯の臨床報告
    　―2016年熊本地震後の産褥EPDS検査を用いた抗うつ効果の後方視野的検討―

    Diagnosis
    　免疫発光測定装置 ルミパルスL2400を用いた
    　　「ルミパルスプレストPSA」の基礎的性能評価

    Cosmetic
    　改良版手専用ピーリングジェルのシミ改善効果
    　センブリ抽出液における有効性と安全性について

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【特集 生活習慣病予防に向けた栄養素機能】

P.1584 掲載の参考文献
1) フレイルに関する日本老年医学会からのステートメント. https://www.jpn-geriat-soc.or.jp/info/topics/pdf/20140513_01_01.pdf
 
2) 荒井秀典 : フレイルの意義. 日老医誌 51 : 497-501, 2014.
 
3) 葛谷雅文 : サルコペニアの診断・病態・治療. 日老会誌 52 : 343-349, 2015.
 
4) 田中清 : ビタミン不足の臨床的・社会的意義に関する研究. ビタミン 93 : 325-333, 2019.
Medical*Online
5) 津川尚子 : 血清25-ヒドロキシビタミンD濃度測定の保険収載とビタミンD欠乏・不足の判定指針. ビタミン 91 : 201-203, 2017.
Medical*Online
6) Okazaki R, Ozono K, Fukumoto S et al : Assessment criteria for vitamin D deficiency/insufficiency in Japan-proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society. J Bone Miner Metab 35 : 1-5, 2017.
 
7) Yoshimura N, Muraki S, Oka H et al : Profiles of vitamin D insufficiency and deficiency in Japanese men and women : association with biological, environmental, and nutritional factors and coexisting disorders : the ROAD study. Osteoporos Int 24 : 2775-2787, 2013.
PubMed
8) Miyauchi M, Hirai C, Nakajima H et al : The solar exposure time required for vitamin D3 synthesis in the human body estimated by numerical simulation and observation in Japan. J Nutr Sci Vitaminol 59 : 257-263, 2013.
PubMed
9) Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al : Effect of vitamin D on falls : a meta-analysis. JAMA 291 : 1999-2006, 2004.
 
10) Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB et al : Fall prevention with supplemental and active forms of vitamin D : a meta-analysis of randomised controlled trials. BMJ 339 : b3692, 2009.
PubMed
11) Murad MH, Elamin KB, Abu Elnour NO et al : The effect of vitamin D on falls : a systematic review and meta-analysis. J Clin Endocrinol Metab 96 : 2997-3006, 2011.
 
12) Bolland MJ, Grey A, Gamble GD et al : Vitamin D supplementation and falls : a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2 : 573-580, 2014.
 
13) Scragg R. Emerging Evidence of Thresholds for Beneficial Effects from Vitamin D Supplementation. Nutrients 10 : 561, 2018.
PubMed
14) Shimizu Y , Kim H , Y oshida H e t al : Serum 25-hydroxyvitamin D level and risk of falls in Japanese community-dwelling elderly women : a 1-year follow-up study. Osteoporos Int 26 : 2185-2192, 2015.
 
15) Wong YY, McCaul KA, Yeap BB et al : Low vitamin D status is an independent predictor of increased frailty and all-cause mortality in older men : the Health in Men Study. J Clin Endocrinol Metab 98 : 3821-3828, 2013.
PubMed
16) Zhou J, Huang P, Lin P et al : Association of vitamin D deficiency and frailty : A systematic review and meta-analysis. Maturitas 94 : 70-76, 2016.
 
17) Dent E, Lien C, Lim WS et al : The Asia-Pacific clinical practice guidelines for the management of frailty. J Am Med Dir Assoc 18 : 564-575, 2017.
 
18) Kuwabara A, Tsugawa N, Mizuno K et al : A simple questionnaire for the prediction of vitamin D deficiency in Japanese adults (Vitamin D Deficiency questionnaire for Japanese : VDDQ-J). J Bone Miner Metab 37 : 854-863, 2019.
 
P.1592 掲載の参考文献
1) 厚生労働省 : 日本人の食事摂取基準 2015年版
 
2) 日本動脈硬化学会 : 動脈硬化性疾患予防ガイドライン 2017年版
Medical*Online
3) Keys A : Coronary heart disease in seven countries. 1970. Nutrition 13 : 250-252, 1997.
PubMed
4) Keys A, Aravanis C, Blackburn HW et al : Epidemiological studies related to coronary heart disease : characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl 460 : 1-392, 1966.
PubMed
5) Steinberg D : Thematic review series : the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy : part II : the early evidence linking hypercholesterolemia to coronary disease in humans. J Lipid Res 46 : 179-190, 2005.
PubMed
6) Kris-Etherton PM, Yu S : Individual fatty acid effects on plasma lipids and lipoproteins : human studies. Am J Clin Nutr 65 (suppl) : 1628S-1644S, 1997.
 
7) Keys A, Parlin RW : Serum cholesterol response to changes in dietary lipids. Am J Clin Nutr 19 : 175-181, 1966.
 
8) Hegsted DM, McGandy RB, Myers ML et al : Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 17 : 281-295, 1965.
 
9) Nakamura Y, Okuda N, Turin TC et al : Fatty acids intakes and serum lipid profiles : NIPPON DATA90 and the national nutrition monitoring. J Epidemiol 20 (Suppl 3) : S544-548, 2010.
 
10) Guo Z, Miura K, Turin TC et al : Relationship of the polyunsaturated to saturated fatty acid ratio to cardiovascular risk factors and metabolic syndrome in Japanese : the INTERLIPID study. J Atheroscler Thromb 17 : 777-784, 2010.
PubMed
11) Mensink RP, Zock PL, Kester AD et al : Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins : a metaanalysis of 60 controlled trials. Am J Clin Nutr 77 : 1146-1155, 2003.
PubMed
12) Takeuchi H, Nishimura Y, Ohmori A et al : Supplementation with 1% energy trans fatty acids had little effect on serum cholesterol levels in healthy young Japanese women. Biosci Biotechnol Biochem 77 (6) : 1219-1222, 2013.
 
13) Takeuchi H, Nishimura Y, Ohmori A et al : Little Effect of Supplementation with 0.6% Energy Trans Fatty Acids on Serum Cholesterol Levels in Adult Japanese Women. J Nutr Sci Vitaminol (Tokyo) 61 (5) : 422-425, 2015.
 
14) Hu FB, Willett WC : Optimal diets for prevention of coronary heart disease. JAMA 288 : 2569-2578, 2002.
PubMed
15) Hannon BA, Thompson SV, An R et al : Clinical outcomes of dietary replacement of saturated fatty acids with unsaturated fat sources in adults with overweight and obesity : A systematic review and meta-analysis of randomized control trials. Ann Nutr Metab 71 : 107-117, 2017.
PubMed
16) Bays A : Clinical overview of omacor : a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol 98 (suppl) : 71i-76i, 2006.
 
17) Yokoyama M, Origasa H, Matsuzaki M et al : Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS) : a randomised open-label, blinded endpoint analysis. Lancet 369 : 1090-1098, 2007.
PubMed
18) Mozaffarian D, Wu JHY : Omega-3 fatty acids and cardiovascular disease. J Am Coll Cardiol 58 : 2047-2067, 2011.
PubMed
19) Harris WS : n-3 fatty acids and serum lipoproteins : human studies. Am J Clin Nutr 65 (suppl) : 1645S-1654S, 1997.
 
20) Bernstein AM, Ding EL, Willett WC et al : A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. J Nutr 142 : 99-104, 2012.
PubMed
21) Hersher R : Are drugmakers fishing for a market with prescription omega-3s? Nat Med 18 : 6, 2012.
PubMed
23) Hooper L, Martin N, Abdelhamid A et al : Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev : CD011737, 2015.
PubMed
24) Mozaffarian D, Micha R, Wallace S : Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat : a systematic review and meta-analysis of randomized controlled trials. PLoS Med 7 : e1000252, 2010.
PubMed
25) Hooper L, Summerbell CD, Thompson R et al : Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev : CD002137, 2011.
 
26) Iso H, Kobayashi M, Ishihara J et al : Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese : the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113 : 195-202, 2006.
PubMed
27) Bhatt DL, Steg PG, Miller M et al : REDUCE-IT Investigators. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med 380 (1) : 11-22, 2019.
PubMed
28) Vafeiadou K, Weech M, Altowaijri H et al : had no impact on vascular function but beneficial effects on lipid biomarkers, E-selectin, and blood pressure : results from the randomized, controlled Dietary Intervention and VAScular function (DIVAS) study. Am J Clin Nutr 102 : 40-48, 2015.
PubMed
29) Wardlaw GM, Snook JT : Effect of diets high in butter, corn oil, or high-oleic acid sunflower oil on serum lipids and apolipoproteins in men. Am J Clin Nutr 51 : 815-821, 1990.
PubMed
30) Chowdhury R, Warnakula S, Kunutsor S et al : Association of dietary, circulating, and supplement fatty acids with coronary risk : a systematic review and meta-analysis. Ann Intern Med 160 : 398-406, 2014.
 
31) de Oliveira Otto MC, Wu JH, Baylin A et al : Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2 : e000506, 2013.
PubMed
32) Farvid MS, Ding M, Pan A et al : Dietary linoleic acid and risk of coronary heart disease : a systematic review and meta-analysis of prospective cohort studies. Circulation 130 : 1568-1578, 2014.
PubMed
33) Estruch R, Ros E, Salas-Salvado J et al : Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368 : 1279-1290, 2013.
 
34) Jakobsen MU, O'Reilly EJ, Heitmann BL et al : Major types of dietary fat and risk of coronary heart disease : a pooled analysis of 11 cohort studies. Am J Clin Nutr 89 : 1425-1432, 2009.
PubMed
35) Knomhout D, Menotti A, Bloemberg B et al : Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease : the Seven Countries Study. Prev Med 24 : 308-315, 1995.
 
36) Denke MA : The effects of trans fatty acid ingestion on serum lipid concentration. Am J Clin Nutr 62 : 693s-700s, 1995
 
37) Willett WC, Stampfer MJ, Manson JE et al : Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341 : 581-585, 1993.
PubMed
38) Hu FB, Stampfer MJ, Manson JE et al : Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337 (21) : 1491-1499, 1997.
PubMed
39) Willett WC : Dietary fats and coronary heart disease. J Intern Med 272 (1) : 13-24, 2012.
PubMed
40) Oomen CM, Ocke MC, Feskens EJ et al : Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study : a prospective population-based study. Lancet 357 (9258) : 746-751, 2001.
PubMed
41) Gebauer SK, Chardigny M, Jakobsen MU et al : Effects of ruminant trans fatty acids on cardiovascular disease and cancer : a comprehensive review of epidemiological, clinical, and mechanistic study. Adv Nutr 2 (4) : 332-354, 2011.
 
P.1599 掲載の参考文献
1) Adibi SA : Influence of dietary deprivations on plasma concentration of free amino acids of man. J Appl Physiol 25 (1) : 52-57, 1968.
 
2) Felig P, Marliss E, Cahill GF Jr : Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281 (15) : 811-816, 1969.
PubMed
3) Lynch CJ, Adams SH : Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol 10 (12) : 723-736, 2014.
PubMed
4) Newgard CB, An J, Bain JR et al : A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9 (4) : 311-26, 2009.
PubMed
5) Shimomura Y, Honda T, Shiraki M et al : Branched-chain amino acid catabolism in exercise and liver disease. J Nutr 136 : 250S-253S, 2006.
PubMed
6) Hutson SM, Berkich D, Drown P et al : Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. J Neurochem 71 : 863-874, 1998.
PubMed
7) Suryawan A, Hawes JW, Harris RA et al : A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr 68 (1) : 72-81, 1998.
PubMed
8) Neinast MD, Jang C, Hui S et al : Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab 29 (2) : 417-429, 2019.
PubMed
9) 下村吉治 : 分岐鎖アミノ酸 (BCAA) 代謝の調節機構. 化学と生物 47 : 480-485, 2009.
 
10) Shimomura Y, Paxton R, Ozawa T et al : Purification of branched chain α-ketoacid dehydrogenase complex from rat liver. Anal Biochem 163 : 74-78, 1987.
 
11) She P, Reid TM, Bronson SK et al : Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab 6 (3) : 181-194, 2007.
PubMed
12) Joshi MA, Jeoung NH, Obayashi M et al : Impaired growth and neurological abnormalities in branched-chain alpha-keto acid dehydrogenase kinase-deficient mice. Biochem J 400 (1) : 153-162, 2006.
PubMed
13) Ishikawa T, Kitaura Y, Kadota Y et al : Muscle-specific deletion of BDK amplifies loss of myofibrillar protein during protein undernutrition. Sci Rep 7 : 39825, 2017.
PubMed
14) Um SH, Frigerio F, Watanabe M et al : Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 : 200-205, 2004.
PubMed
15) Um SH, D'Alessio D, Thomas G : Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3 : 393-402, 2006.
PubMed
16) Newgard CB : Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab 15 (5) : 606-614, 2012.
PubMed
17) Bhattacharya S, Granger CB, Craig D et al : Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. Atherosclerosis 232 (1) : 191-196, 2014.
PubMed
18) Fontana L, Cummings NE, Arriola Apelo SI et al : Decreased consumption of branched-chain amino acids improves metabolic health. Cell Rep 16 (2) : 520-530, 2016.
PubMed
19) Pedersen HK, Gudmundsdottir V, Nielsen HB et al : Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 : 376-381, 2016.
PubMed
20) Jang C, Oh SF, Wada S et al : A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med 22 (4) : 421-426, 2016.
 
21) White PJ, Lapworth AL, An J et al : Branchedchain amino acid restriction in Zucker-fatty rats improves muscle insulinsensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export. Mol Metab 5 (7) : 538-551, 2016.
 
22) Lerin C, Goldfine AB, Boes T et al : Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism. Mol Metab 5 (10) : 926-936, 2016.
PubMed
23) Wang Q, Holmes MV, Davey Smith G et al : Genetic Support for a Causal Role of Insulin Resistance on Circulating Branched-Chain Amino Acids and Inflammation. Diabetes Care 40 (12) : 1779-1786, 2017.
PubMed
24) Yu D, Arriola Apelo SI, Cottrell SE et al : Restoration of metabolic health by decreased consumption of branched-chain amino acids. J Physiol 596 (4) : 623-645, 2018.
PubMed
25) Nishitani S, Takehana K, Fujitani S et al : Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 288 : G1295-G1300, 2005.
 
26) Kadota Y, Kazama S, Bajotto G et al : Clofibrate-induced reduction of plasma branched-chain amino acid concentrations impairs glucose tolerance in rats. JPEN J Parenter Entral Nutr 36 (3) : 337-343, 2012.
 
27) 太田美樹, 北浦靖之, 門田吉弘 他 : 糖代謝に対する分岐鎖アミノ酸 (BCAA) 濃度低下の影響. 第70回日本栄養・食糧学会講演要旨集, p.263, 日本栄養・食糧学会, 東京, 2016.
 
28) Brunetta HS, de Camargo CQ, Nunes EA : Does L-leucine supplementation cause any effect on glucose homeostasis in rodent models of glucose intolerance? A systematic review. Amino Acids 50 : 1663-1678, 2018.
 
29) Zhao X, Han Q, Liu Y et al : The relationship between branched-chain amino acid related metabolomics signature and insulin resistance : a systematic review. J Diabetes Res 2016 : 2794591, 2016.
 
30) Woo SL, Yang J, Hsu M et al : Effects of branched-chain amino acids on glucose metabolism in obese, prediabetic men and women : a randomized, crossover study. Am J Clin Nutr 109 (6) : 1566-1577, 2019.
 
31) Kawaguchi T, Izumi N, Charlton MR et al : Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology 54 : 1063-1070, 2011.
PubMed
32) Nagata C, Nakamura K, Wada K et al : Branchedchian amino acid intake and the risk of diabetes in a Japanese community : the Takayama study. Am J Epidemiol 178 (8) : 1226-1232, 2013.
 
33) Petersen MC, Shulman GI : Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev 98 (4) : 2133-2223, 2018.
PubMed
34) Yang Q, Vijayakumar A, Kahn BB : Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol 19 (10) : 654-672, 2018.
 
35) Neinast M, Murashige D, Arany Z : Branched-chain amino acids. Annu Rev Physiol 81 : 139-164, 2019.
PubMed
36) Roberts LD, Bostrom P, O'Sullivan JF et al : β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab 19 (1) : 96-108, 2014.
 
37) Shi CX, Zhao MX, Shu XD et al : β-Aminoisobutyric acid attenuates hepatic endoplasmic reticulum stress and glucose/lipid metabolic disturbance in mice with type 2 diabetes. Sci Rep 6 : 21924, 2016.
 
38) Tanianskii DA, Jarzebska N, Birkenfeld AL et al : Beta-Aminoisobutyric acid as a novel regulator of carbohydrate and lipid metabolism. Nutrients 11 (3) : E524, 2019.
 
39) Wang TJ, Larson MG, Vasan Rs et al : Metabolic profiles and the risk of developing diabetes. Nat Med 17 (4) : 448-453, 2011.
PubMed
40) Bifari F, Nisoli E : Branched-chain amino acids differently modulate catabolic and anabolic states in mammals : a pharmacological point of view. Brit J Pharmacol 174 : 1366-1377, 2017.
 
41) Kuzuya T, Katano Y, Nakano I et al : Regulation of branched-chain amino acid catabolism in rat models for spontaneous type 2 diabetes mellitus. Biochem Biophys Res Commun 373 : 94-98, 2008.
PubMed
42) Doisaki M, Katano Y, Nakano I et al : Regulation of hepatic branched-chain α-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. Biochem Biophys Res Commun 393 : 303-307, 2010.
 
P.1609 掲載の参考文献
1) Saneei P, Larijani B, Esmaillzadeh A : Rice consumption, incidence of chronic diseases and risk of mortality : meta-analysis of cohort studies. Public Health Nutr 20 (2) : 233-244, 2016.
PubMed
2) Krittanawong C, Tunhasiriwet A, Zhang H et al : Is white rice consumption a risk for metabolic and cardiovascular outcomes? A systematic review and meta-analysis. Heart Asia 9 : 1-7, 2017.
PubMed
3) Kadowaki M, Kubota M, Watanabe R : Physiological multifunctions of rice proteins of endosperm and bran. J Nutr Sci Vitaminol 65 : S42-S47, 2019.
 
4) 厚生労働省 : 平成29年国民健康・栄養調査報告, 2017. https://www.mhlw.go.jp/content/000451755.pdf
 
5) Kubota M, Watanabe R, Kabasawa H et al : Rice protein ameliorates the progression of diabetic nephropathy in Goto-Kakizaki rats with high-sucrose feeding. Br J Nutr 110 : 1211-1219, 2013.
PubMed
6) Kubota, M, Watanabe R, Yamaguchi M et al : Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats. Br J Nutr 116 : 1326-1335, 2016.
PubMed
7) Anderson JW, Blake JE, Turner J et al : Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 68 : 1347S-1353S, 1998.
PubMed
8) Teixeira SR, Tappenden KA, Erdman JW Jr : Altering dietary protein type and quantity reduces urinary lbumin excretion without affecting plasma glucose concentrations in BKS. cg-m+Leprdb/+Leprdb (db/db) mice. J Nutr 133 : 673-678, 2003.
 
9) Teixeira SR, Tappenden KA, Carson LA et al : Isolated soy protein consumption reduces irinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134 : 1874-1880, 2004.
 
10) Trujillo J, Ramirez V, Perez J et al : Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am J Physiol Renal Physiol 288 : F108-F116, 2005.
PubMed
11) Hamann C, Kirschner S, Gunther K-P et al : Bone, sweet bone-osteoporotic fractures in diabetic mellitus. Nature Rev Endocrinol 8 : 297-305, 2012.
 
12) Ochiai M, Kuroda T, Gohtani S et al : Dietary protein derived from dried bonito fish improves type-2 diabetes mellitus-induced bone frailty in Goto-Kakizaki rats. J Food Sci 80 : H848-H856, 2015.
PubMed
13) Fu WJ, Haynes TE, Kohli R et al : Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr 135 : 714-721, 2005.
PubMed
14) Yang L, Kumagai T, Kawamura H et al : Effects of rice protein from two cultivars, Koshihikari and Shunyo, on cholesterol and triglyceride metabolism in growing and adult rats. Biosci Biotechnol Biochem 71 : 693-703, 2007.
 
15) Yang L, Chen JH, Xu T et al : Rice protein improves oxidative stress by regulating glutathione metabolism and attenuating oxidative damage to lipids and proteins in rats. Life Sci 91 : 389-394, 2012.
 
16) Li H, He H, Wang ZX et al : Rice protein suppresses ROS generation and stimulates antioxidant gene expression via Nrf2 activation in adult rats. Gene 585 : 256-264, 2016.
 
17) Boonloh K, Lee ES, Kim HM et al : Rice bran protein hydrolyzates attenuate diabetic nephropathy in diabetic animal model. Eur J Nutr 57 : 761-772, 2018.
 
18) Robertson L, Waugh N, Robertson A : Protein restriction for diabetic renal disease. Cochrane Database Syst Rev : CD002181, 2007.
PubMed
19) Nezu U, Kamiyama H, Kondo Y et al : Effect of low-protein diet on kidney function in diabetic nephropathy : meta-analysis of randomized controlled trials. BMJ Open 3 : e002934, 2013.
PubMed
20) Otoda T, Kanasaki K, Koya D : Low-protein diet for diabetic nephropathy. Curr Diab Rep 14 : 523, 2014.
PubMed
21) Kim JC, Kalantar-Zadeh K, Kopple JD : Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol 24 : 337-351, 2013.
PubMed
22) Hosojima M, Shimada H, Obi Y et al : A randomized, double-blind, crossover pilot trial of rice endosperm protein supplementation in maintenance hemodialysis patients. Sci Rep 7 : 18003, 2017.
PubMed
P.1617 掲載の参考文献
1) Akhlaghi M, Ghobadi S, Mohammad Hosseini M et al : Flavanols are potential anti-obesity agents, a systematic review and meta-analysis of controlled clinical trials. Nutr Metab Cardiovasc Dis 28 (7) : 675-690, 2018.
PubMed
2) Mousavi SM, Milajerdi A, Sheikhi A et al : Resveratrol supplementation significantly influences obesity measures : a systematic review and dose-response meta-analysis of randomized controlled trials. Obes Rev 20 (3) : 487-498, 2019.
 
3) Tajik N, Tajik M, Mack I et al : The potential effects of chlorogenic acid, the main phenolic components in coffee, on health : a comprehensive review of the literature. Eur J Nutr 56 (7) : 2215-2244, 2017.
 
4) Canto C, Gerhart-Hines Z, Feige JN et al : AMPK regulates energy expenditure by modulating NAD+metabolism and SIRT1 activity. Nature 458 (7241) : 1056-1060, 2009.
PubMed
5) Lagouge M, Argmann C, Gerhart-Hines Z et al : Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (6) : 1109-1122, 2006.
PubMed
6) Baur JA, Pearson KJ, Price NL et al : Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (7117) : 337-342, 2006.
PubMed
7) Hwang JT, Kwon DY, Yoon SH : AMP-activated protein kinase : a potential target for the diseases prevention by natural occurring polyphenols. N Biotechnol 26 (1-2) : 17-22, 2009.
 
8) Ayissi VB, Ebrahimi A, Schluesenner H : Epigenetic effects of natural polyphenols : a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res 58 (1) : 22-32, 2014.
PubMed
9) Wang L, Waltenberger B, Pferschy-Wenzig EM et al : Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ) : a review. Biochem Pharmacol 92 (1) : 73-89, 2014.
 
10) Rigano D, Sirignano C, Taglialatela-Scafati O : The potential of natural products for targeting PPAR. Acta Pharm Sin B 7 (4) : 427-438, 2017.
PubMed
11) Matin A, Gavande N, Kim MS et al : 7-Hydroxybenzopyran-4-one derivatives : a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists. J Med Chem 52 (21) : 6835-6850, 2009.
 
12) Sakamoto Y, Naka A, Ohara N et al : Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARγ. Mol Nutr Food Res 58 (4) : 718-726, 2014.
 
13) Teng CT, Hsieh JH, Zhao J et al : Development of Novel Cell Lines for High-Throughput Screening to Detect Estrogen-Related Receptor Alpha Modulators. SLAS Discov 22 (6) : 720-731, 2017.
PubMed
14) 飯田薫子 : 大豆イソフラボンによる転写因子ERRαを介した骨格筋エネルギー代謝関連遺伝子制御の検討. 大豆たんぱく質研究 20 : 89-94, 2018.
 
15) Manach C, Scalbert A, Morand C et al : Polyphenols : food sources and bioavailability. Am J Clin Nutr 79 (5) : 727-747, 2004.
PubMed
16) Tachibana H, Koga K, Fujimura Y et al : A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 11 (4) : 380-381, 2004.
PubMed
P.1622 掲載の参考文献
1) Dahl LK : Role of dietary sodium in essential hypertension. J Am Diet Assoc 34 : 585-590, 1958.
PubMed
2) Fujita T, Henry WL, Bartter FC et al : Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 69 : 334-344, 1980.
PubMed
3) Shibata S, Nagase M, Yoshida S et al : Modification of mineralocorticoid receptor function by rac1 gtpase : Implication in proteinuric kidney disease. Nat Med 14 : 1370-1376, 2008.
PubMed
4) Shibata S, Mu S, Kawarazaki H et al : Rac1 gtpase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest 121 : 3233-3243, 2011.
 
5) Kawakami-Mori F, Shimosawa T, Mu S et al : Nadph oxidase-mediated rac1 gtp activity is necessary for nongenomic actions of the mineralocorticoid receptor in the ca1 region of the rat hippocampus. Am J Physiol Endocrinol Metab. 302 : E425-432, 2012.
PubMed
6) Mu S, Shimosawa T, Ogura S et al : Epigenetic modulation of the renal beta-adrenergic-wnk4 pathway in salt-sensitive hypertension. Nat Med 17 : 573-580, 2011.
PubMed
7) Kawakami-Mori F, Nishimoto M, Reheman L et al : Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension. JCI Insight 3 : e95625, 2018.
PubMed
8) Ueda K, Nishimoto M, Hirohama D et al : Renal dysfunction induced by kidney-specific gene deletion of hsd11b2 as a primary cause of salt-dependent hypertension. Hypertension 70 : 111-118, 2017.
PubMed
P.1627 掲載の参考文献
1) 柳澤裕之 : 知られざる国民病-亜鉛欠乏症-老化促進要因としての亜鉛欠乏症-. 日本臨床内科医会雑誌 24 (1) : 91-95, 2009.
 
2) Yanagisawa H, Sato M, Nodera M et al : Excessive zinc intake elevates systemic blood pressure levels in normotensive rats -Potential role of superoxide-induced oxidative stress-. J Hypertens 22 : 543-550, 2004.
PubMed
3) Yanagisawa H, Miyazaki T, Nodera M et al : Zn-excess intake causes the deterioration of renal function accompanied by an elevation in systemic blood pressure primarily through superoxide radical-induced oxidative stress. Int J Toxicol 33 (4) : 288-296, 2014.
PubMed
4) Sato M, Yanagisawa H, Nojima Y et al : Zn deficiency aggravates hypertension in spontaneously hypertensive rats : Possible role of Cu/Zn-superoxide dismutase. Clin Exp Hypertens 24 (5) : 355-370, 2002.
PubMed
5) Canatan H, Baka I, Akbulut M et al : Relationship among levels of leptin and zinc, copper, and zinc/copper ratio in plasma of patients with essential hypertension and healthy normotensive subjects. Biol Trace Elem Res 100 : 117-123, 2004.
 
6) Kunutsor SK, Laukkanen JA : Serum zinc concentrations and incident hypertension : new findings from a population-based cohort study. J Hypertens 34 : 1055-1061, 2016.
PubMed
7) Kawasaki I, Suzuki Y, Yanagisawa H : Zn deficiency enhances the induction of micronuclei and 8-hydroxy-2'-deoxyguanosine via superoxide radical in bone marrow of zinc-deficient rats. Biol Trace Elem Res 154 : 120-126, 2013.
PubMed
8) Yanagisawa H, Seki Y, Suka M et al : Potential role of mitochondrial damage and S9 mixture including metabolic enzymes in ZnO nanoparticles-induced oxidative stress and genotoxicity in Chinese hamster lung (CHL/IU) cells. Mutat Res Genet Toxicol Environ Mutagen 834 : 25-34, 2018.
PubMed
9) Adachi Y, Toshida J, Kodera Y et al : Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochem Biophys Res Commun 351 : 165-170, 2006.
 

【臨床報告】

P.1633 掲載の参考文献
1) John L. Beard, Michael K. Hendricks, Eva M. Perez et al : Maternal Iron Deficiency Anemia Affects Postpartum Emotions and Cognition. The Journal of Nutrition 135 (2) : 267-272, 2005.
PubMed
2) Cox JL, Holden JM, Sagovsky R : Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150 : 782-786, 1987.
PubMed
3) Michael W. O'hara, Annette M. Swain : Rates and risk of postpartum depression-a meta-analysis. International Review of Psychiatry 8 : 37-54, 1996.
 
4) 河上祥一, 吉田悠晋, 藤江由夏他 : 熊本地震前後における産褥EPDS検査の検討. 日本周産期・新生児医学会雑誌 53 (2) : 728, 2017.
Medical*Online
5) 関場香, 江口勝人, 平松祐司他 : 妊婦の貧血に対する鉄剤と人参養栄湯の併用効果. 産婦人科の世界 45 : 257-261, 1993.
 
6) 宮崎保, 内野治人, 木村郁郎他 : 再生不良性貧血に対する人参養栄湯 (EK-108) の臨床的有用性. 臨床医薬 10 (11) : 2591-2603, 1994.
Medical*Online
7) Murata K, Fujita N, Takahashi R et al : Ninjinyoeito Improves Behavioral Abnormalities and Hippocampal Neurogenesis in the Corticosterone Model of Depression. Front Pharmacol. doi : 10.3389/fphar.2018.01216
 
8) 山田ちひろ, 最上祥子, 菅野仁美他 : 人参養栄湯はドパミンD2受容体を介して新規アパシー様モデルマウスにおける食欲不振ならびに巣作り行動低下を改善する. 薬理と治療 46 (2) : 207-216, 2018.
Medical*Online
9) Kudoh C, Arita R, Honda M et al : Effect of ninjin' yoeito, a Kampo medicine, on cognitive impairment and depression in patients with Alzheimer's disease : 2 years of observation. Psychogeriatrics 2015. doi : 10.1111/psyg.12125
 
10) Miura S, Kawamura I, Yamada A et al : EFFECT OF TRADITIONAL CHINESE HERBAL MEDICINE, REN-SHEN-YANG-TANG (JAPANESE NAME : NINJIN-YOUEI-TO) OF HEMATOPOIETIC STEN CELLS IN MICE. Int J Immunopharmacol 11 : 771-780, 1989.
 
11) Harada N, Okamura S, Shimoda K et al : INFLUENCE OF A TRADITINAL CHINESE HERBEL MEDICINE, REN-SHEN-YANG-RONG-TANG (JAPANESE NAME : NINJIN-YOEI-TO) ON THE PRODUCTION OF INTERLEUKIN 6 FROM PERIPHERAL BLOOD MONONUCLEAR CELLS AND BONE MARROW ADHERENT CELLS. Int J Immunotherapy 8 : 141-145, 1992.
 
12) Okamura S, Shimoda K, Li Xin Yu et al : A TRADITINAL CHINESE HERBEL MEDICINE, RENSHEN-YANG-RONG-TANG (JAPANESE NAME : NINJIN-YOEI-TO) AUGMENTS THE PRODUCTION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FROM HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS IN VITRO. Int J Immunopharmacol 13 : 595-598, 1991.
 
13) Kojima Y, Kumazawa Y, Shibukawa N et al : Screening for interferon inducers and mitogens among various medical plants used in traditional Sino-Japanese Medicine. Proc Symp WAKANYAKU 13 : 101-103, 1980.
 
14) 佐藤喜根子 : 東日本大震災が母親のメンタルヘルスに与えた影響. 助産雑誌 66 (10) : 858-863, 2012.
 
15) Yuan Hu, Ming Liu, Ping Liu et al : Possible mechanism of the antidepressant effect of 3,6'-disinapoyl sucrose from Polygala tenuifolia Willd. Journal of Pharmacy and Pharmacology 63 : 869-874, 2011.
PubMed
16) 藤田日奈, 村田健太 : 人参の抗うつ作用および疲労に対する効果. phil漢方 65 : 24-25, 2017.
 
17) 小林義典, インドラ・ダット・バット : 白朮精油の抗うつ作用. Aroma Research 6 (4) : 356-361, 2005.
Medical*Online
18) Ito A, Shin N, Tsuchida T et al : Antianxiety-Like Effects of Chimpi (Dried Citrus Peels) in the Elevated Open-Platform Test. Molecules 18 : 10014-10023, 2013.
PubMed

【Diagnosis】

P.1641 掲載の参考文献
1) 加野象次郎 : 前立腺特異抗原 (PSA) の標準化に関する活動報告 21 (1) : 9-47, 2006.
 
2) 石橋みどり : PSA-検査編. 臨床検査 59 (7) : 644-654, 2015.
 

【Cosmetic】

P.1646 掲載の参考文献
1) 今原広次, 伊東泰美 : メラニン形成におよぼすプラセンタエキスラクトの影響. 粧技誌 16 (1) : 10-14, 1982.
 
2) 宇山光男, 岡部美代治 : 化粧品成分ガイド 第5版. p123, フレグランスジャーナル社, 東京, 2001.
 
3) 田中芳明 : 酸化ストレスと抗酸化療法. 亜鉛栄養治療 7 (1) : 4-13, 2016.
 
4) サントリーウエルネス株式会社 サントリー健康科学研究所. https://health.suntory.co.jp/koubo/〔2019年9月20日〕
 
5) 株式会社マツモト交商 : ラナクリス コンセプトシート. 2009. 9. 1
 
6) 木下勝寿, 堀川麻子 他 : 手専用ピーリングジェルのシミ改善効果. 医学と薬学74 (7) : 841-843, 2017.
 
P.1650 掲載の参考文献
1) 鈴木真理, 蜷川よしみ, 細川かをり, 荻野泰子, 蜷川よしみ : オレアノール酸配合育毛剤の臨床試験結果. 皮膚 31 (4) : 541-547, 1989.
 
2) 早川律子, 松永佳世子, 鈴木真理他 : センブリ抽出物配合育毛剤の皮膚安全性試験. 皮膚 30 (2) : 136-143, 1988.
 
3) 鈴木真理, 蜷川よしみ, 細川かをり他 : オレアノール酸配合育毛剤の臨床試験結果. 皮膚 31 (4) : 541-542, 1989.
 
4) 鈴木真理, 蜷川よしみ, 細川かをり他 : オレアノール酸配合育毛剤の臨床試験結果. 皮膚 31 (4) : 544, 1989.
 
5) 鈴木真理, 蜷川よしみ, 細川かをり他 : オレアノール酸配合育毛剤の臨床試験結果. 皮膚 31 (4) : 544, 1989.
 
6) 高橋省三, 諸橋正昭 : コラージュリッチの女性脱毛症患者に対する使用成績. 西日本皮膚科 53 (2) : 360-367, 1991.
 
7) 早川律子, 松永佳世子, 鈴木真理他 : センブリ抽出物配合育毛剤の皮膚安全性試験. 皮膚 30 (2) : 136, 1988.
 
8) 早川律子, 松永佳世子, 鈴木真理他 : センブリ抽出物配合育毛剤の皮膚安全性試験. 皮膚 30 (2) : 142, 1988.
 
9) 川村太郎, 笹川正二, 増田勉, 本田史朗, 木下正子, 原田昭太郎, 石崎 達, 永井隆吉, 広川浩一, 安西喬, 姉小路公久, 肥田野信, 川野正, 池上一郎, 佐藤重男, 青山卓夫 : 貼布試験標準化の基礎的研究. 日皮会誌 80 (5) : 301-314, 1970.
 
10) 川村太郎, 笹川正二, 増田勉他 : 貼布試験標準化の基礎的研究. 日皮会誌 80 (5) : 301-314, 1970.
 
11) 川村太郎, 笹川正二, 増田勉他 : 貼布試験標準化の基礎的研究. 日皮会誌 80 (5) : 301-314, 1970.
 
12) 早川律子, 松永佳世子, 鈴木真理他 : センブリ抽出物配合育毛剤の皮膚安全性試験. 皮膚 30 (2) : 142, 1988.
 

書評

最近チェックした商品履歴

Loading...